Visa, Mastercard to Pay $167.5 Million to Settle ATM User Fee Lawsuit

The Epoch Times
Visa and Mastercard will pay $167.5 million to settle a 2011 lawsuit alleging inflated ATM fees due to an unlawful conspiracy.

Summary

Visa and Mastercard have reached a settlement of $167.5 million to resolve a class action lawsuit dating back to 2011. The lawsuit, filed in the U.S. District Court for the District of Columbia, claimed that Visa and Mastercard engaged in an “unlawful conspiracy to restrain trade” concerning surcharge fees imposed by independent, nonbank ATMs. Plaintiffs alleged this collusion resulted in higher ATM access fees for consumers. The Dec. 18 court filing marks the conclusion of the 14-year-old case, bringing financial relief to those affected by the alleged fee manipulation.

(Source:The Epoch Times)

WBRZ

$5M lawsuit claims Disney's California theme parks illegally collect facial recognition data

CP24 Toronto

Judge approves class action lawsuit launched by Quebec TV personality

The Bradenton Times

Maryland reaches $4.1M settlement with homebuilder in sediment pollution case

Tekedia

Tether Invests on LemFi to Accelerate Stablecoin Settlement Flow in Africa and Asia

Headtopics

President Trump, Family, and Businesses Shielded from Pending Tax Audits as Part of DOJ Settlement

Bitcoin News

Evernorth Highlights XRP’s ‘Actual Story’ Beyond JPMorgan Settlement Attention

Punch

SEC fixes June 1 for T+1 settlement cycle transition

Firstpost

Why is Trump’s new IRS settlement triggering allegations of ‘self-dealing’?

Syracuse Ny Local News

Government to permanently drop tax claims against Trump family as part of lawsuit settlement

USA TODAY

Disney sued over facial recognition at California theme parks

New York Post

Disneyland targeted in class-action lawsuit claiming new program is violating guests' privacy

Bangor Daily News

Journalists sue tech giants over 'stolen' voices for AI training

The Mercury News

Disneyland hit with $5 million lawsuit over use of facial recognition technology

Devdiscourse

UPDATE 4-Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

The Japan Times

Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury